Clinical Trials Related to Chronic Lymphocytic Leukemia

Related studies linked through entity extraction aliases.

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Status: RECRUITING
Phase: PHASE2

Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk

Status: RECRUITING
Phase: NA

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Status: RECRUITING
Phase: PHASE2

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Status: RECRUITING
Phase: PHASE3

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

Status: NOT_YET_RECRUITING
Phase: N/A

Exercise As Intervention in Chronic Lymphocytic Leukemia

Status: ACTIVE_NOT_RECRUITING
Phase: NA

Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia

Status: RECRUITING
Phase: NA

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Status: NOT_YET_RECRUITING
Phase: PHASE2

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Status: NOT_YET_RECRUITING
Phase: NA

A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan

Status: COMPLETED
Phase: N/A

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

Status: RECRUITING
Phase: PHASE2

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry

Status: RECRUITING
Phase: N/A

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Status: COMPLETED
Phase: N/A

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

Status: ENROLLING_BY_INVITATION
Phase: N/A

Acalabrutinib Real World Italian obSErvational Study -ARISE

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Status: RECRUITING
Phase: N/A

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Status: RECRUITING
Phase: PHASE3